Showing results (141-150 of 293) with videos related to

Sort By:
Pageof 30
Expert Opinion on Therapeutic Patents|June 17, 2015
Deubiquitinases (DUBs) and DUB inhibitors: a patent reviewPershang Farshi, Rahul R Deshmukh, Joseph O Nwankwo, et al.
Bioorganic & Medicinal Chemistry|February 25, 2005
Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitorsSheng Biao Wan, Kristin R Landis-Piwowar, Deborah J Kuhn, et al.
Journal of Cellular Physiology|December 9, 2008
Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cellsKannagi Chinnakannu, Di Chen, Yiwei Li, et al.
International Journal of Molecular Medicine|November 6, 2007
Evaluation of copper-dependent proteasome-inhibitory and apoptosis-inducing activities of novel pyrrolidine dithiocarbamate analoguesZhiyong Yu, Fei Wang, Vesna Milacic, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
PI-3 kinase p110β: a therapeutic target in advanced prostate cancersBenyi Li, Aijing Sun, Wencong Jiang, et al.
International Journal of Molecular Medicine|March 9, 2005
Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugsKristin R Landis-Piwowar, Deborah J Kuhn, Sheng Biao Wan, et al.
Cancer Research|September 17, 2008
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivoVesna Milacic, Sanjeev Banerjee, Kristin R Landis-Piwowar, et al.
International Journal of Molecular Medicine|September 12, 2006
Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunitKenyon G Daniel, Kristin R Landis-Piwowar, Di Chen, et al.
Molecular Cancer Therapeutics|April 14, 2005
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancerXinbo Liao, Siqing Tang, J Brantley Thrasher, et al.
Pageof 30